Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects
about
Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal OxaliplatinDevelopment of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: is it feasible?Pharmacodynamics-mediated drug disposition (PDMDD) and precursor pool lifespan model for single dose of romiplostim in healthy subjects.A Systems Pharmacology Model of Erythropoiesis in Mice Induced by Small Molecule Inhibitor of Prolyl Hydroxylase Enzymes.Interpretation of transit compartments pharmacodynamic models as lifespan based indirect response modelsComparative performance of cell life span and cell transit models for describing erythropoietic drug effectsTwo different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty.Population pharmacokinetic and pharmacodynamic model-based comparability assessment of a recombinant human Epoetin Alfa and the Biosimilar HX575.Models for the red blood cell lifespan.Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cells.Pharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular response.Pharmacodynamic Model of Hepcidin Regulation of Iron Homeostasis in Cynomolgus MonkeysLifespan based indirect response models.Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.Modeling of delays in PKPD: classical approaches and a tutorial for delay differential equations.Pharmacodynamic models of age-structured cell populations.Assessment of hemoglobin responsiveness to epoetin alfa in patients on hemodialysis using a population pharmacokinetic pharmacodynamic model.Exposure-response modeling of darbepoetin alfa in anemic patients with chronic kidney disease not receiving dialysis.Pharmacokinetic and pharmacodynamic modeling of romiplostim in animals.Determination of hemoglobin mass in humans by measurement of CO uptake during inhalation of a CO-air mixture: a proof of concept studyPrediction of Human Pharmacokinetics from Preclinical Information of Rhein, an Antidiabetic Nephropathy Drug, Using a Physiologically Based Pharmacokinetic Model
P2860
Q33427607-1B1BC1AC-CBF0-4416-A18E-A85ADDC3F503Q33824163-74276CD6-5D89-4A32-A684-E62AC94BDC4FQ34293586-B038C77C-7C9F-4344-88DD-1E9A940879D0Q35179547-53712CB2-18BC-4F50-AF76-04093871D1E2Q35226129-5A5A664F-FA7D-4E98-ADCC-41837B11E208Q35595803-AFBF724A-A8F7-4DBA-ACF2-B1A269962837Q35851261-DB6C2D10-D5DF-43DB-8C4D-254F38BBA589Q36354544-33E58098-AA9D-4FB9-835C-4E5937BAC267Q36952011-68AA651B-50C4-4862-9F74-11757CE9F0F2Q37170126-8A51A494-E03E-4E1D-9F4E-632B7CEB94B9Q37363462-A24C912B-505D-43C0-97D8-F2221E52C196Q37600377-6AC123D7-9CCF-4C9F-BC08-D3268608D97BQ37972792-0A3987A8-7979-4347-82C9-7422E149141BQ38126361-D1BD1704-0198-4076-B6FC-85012501E4A6Q38241696-FC9C046D-07EF-4080-A780-0F2657EC80DFQ38588105-5C608CD8-14CF-4068-9C32-19DBC1F7CA4FQ41021058-B10C40B3-EBA1-497B-9815-76C6D320ECD9Q46028013-122086C2-8928-4FBB-9A5E-CA5954FF16DBQ46358056-74A6F894-C459-40B6-9032-26C5A513CF66Q57165921-E2378E2D-FDF3-47A6-8846-0C7EBD2487A7Q57269392-7CA8C387-B362-4178-9EB0-AB0BFFB54143
P2860
Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Pharmacodynamic analysis of re ...... stribution in healthy subjects
@ast
Pharmacodynamic analysis of re ...... stribution in healthy subjects
@en
type
label
Pharmacodynamic analysis of re ...... stribution in healthy subjects
@ast
Pharmacodynamic analysis of re ...... stribution in healthy subjects
@en
prefLabel
Pharmacodynamic analysis of re ...... stribution in healthy subjects
@ast
Pharmacodynamic analysis of re ...... stribution in healthy subjects
@en
P2093
P2860
P1476
Pharmacodynamic analysis of re ...... stribution in healthy subjects
@en
P2093
Jeremy Hing
Juan José Pérez-Ruixo
Wojciech Krzyzanski
P2860
P304
P356
10.2165/00003088-200847060-00004
P577
2008-01-01T00:00:00Z
P5875
P6179
1002321702